Status:
AVAILABLE
Eculizumab (Soliris) in Covid-19 Infected Patients
Lead Sponsor:
Hudson Medical
Conditions:
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
Covid-19 has spread rapidly throughout the world causing widespread panic, death, and injury. While this virus is the provocateur, it is often the patient's own disproportionate immune response which ...
Detailed Description
Recorded Endpoints: * Mortality * Time in the ICU * Time on a ventilator Administrative: An Emergency FDA IND must be submitted (FDA form 3926) for each patient. Subsequent to approval the primary...
Eligibility Criteria
Inclusion
- Age 18 or older.
- Confirmed Covid-19 infection
- ARDS
- ICU patient
Exclusion
- Active Neisseria infection.
- Concomitant enrollment in another experimental/off-label immunosuppressive therapy trial.
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04288713
Last Update
March 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.